Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)

Clinical trial NCT01111851 · COMPLETED

Trial details

NCT number: NCT01111851
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting (CINV)

Start date: 2010-04-01
Primary completion: 2010-10-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.